| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4166428
Max Phase: Preclinical
Molecular Formula: C19H22N4O2S
Molecular Weight: 370.48
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(O)CCC1CCN(Cc2ccc3c(c2)Nc2nccnc2S3)CC1
Standard InChI: InChI=1S/C19H22N4O2S/c24-17(25)4-2-13-5-9-23(10-6-13)12-14-1-3-16-15(11-14)22-18-19(26-16)21-8-7-20-18/h1,3,7-8,11,13H,2,4-6,9-10,12H2,(H,20,22)(H,24,25)
Standard InChI Key: ZZSWVFLELIDCDA-UHFFFAOYSA-N
Associated Targets(Human)
Intercellular adhesion molecule-1 260 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 370.48 | Molecular Weight (Monoisotopic): 370.1463 | AlogP: 3.76 | #Rotatable Bonds: 5 |
| Polar Surface Area: 78.35 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.32 | CX Basic pKa: 8.42 | CX LogP: 0.31 | CX LogD: 0.28 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -0.88 |
References
| 1. Pluta K, Jeleń M, Morak-Młodawska B, Zimecki M, Artym J, Kocięba M, Zaczyńska E.. (2017) Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties., 138 [PMID:28734245] [10.1016/j.ejmech.2017.07.009] |
Source
Source(1):